Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOCLOPRAMIDE Cause Toxic epidermal necrolysis? 165 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Toxic epidermal necrolysis have been filed in association with METOCLOPRAMIDE (metoclopramide hydrochloride). This represents 1.5% of all adverse event reports for METOCLOPRAMIDE.

165
Reports of Toxic epidermal necrolysis with METOCLOPRAMIDE
1.5%
of all METOCLOPRAMIDE reports
130
Deaths
82
Hospitalizations

How Dangerous Is Toxic epidermal necrolysis From METOCLOPRAMIDE?

Of the 165 reports, 130 (78.8%) resulted in death, 82 (49.7%) required hospitalization, and 68 (41.2%) were considered life-threatening.

Is Toxic epidermal necrolysis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOCLOPRAMIDE. However, 165 reports have been filed with the FAERS database.

What Other Side Effects Does METOCLOPRAMIDE Cause?

Nausea (1,080) Drug ineffective (927) Off label use (926) Drug hypersensitivity (751) Vomiting (672) Dyspnoea (525) Headache (499) Diarrhoea (481) Hypersensitivity (473) Tardive dyskinesia (465)

What Other Drugs Cause Toxic epidermal necrolysis?

ACETAMINOPHEN (980) LAMOTRIGINE (941) ALLOPURINOL (858) IBUPROFEN (764) SULFAMETHOXAZOLE\TRIMETHOPRIM (592) CIPROFLOXACIN (576) FUROSEMIDE (521) VANCOMYCIN (515) PIPERACILLIN\TAZOBACTAM (490) PEMBROLIZUMAB (444)

Which METOCLOPRAMIDE Alternatives Have Lower Toxic epidermal necrolysis Risk?

METOCLOPRAMIDE vs METOLAZONE METOCLOPRAMIDE vs METOPIMAZINE METOCLOPRAMIDE vs METOPROLOL METOCLOPRAMIDE vs METRELEPTIN METOCLOPRAMIDE vs METRONIDAZOLE

Related Pages

METOCLOPRAMIDE Full Profile All Toxic epidermal necrolysis Reports All Drugs Causing Toxic epidermal necrolysis METOCLOPRAMIDE Demographics